Show me the Canadian money!
Canadian small and mid-sized businesses (SMEs) are often the drivers of industry change, developing innovative solutions to complex problems. These solutions can increase productivity, reduce technical barriers, and provide new capabilities that expand product and service offerings. However, for many small businesses in Canada, a lack of resources restricts the amount of research, development, and commercialization that a business can execute.
Canadian government funding provided through the National Research Council (NRC) enables SMEs to move technical projects forward at reduced expense and risk. The Industrial Research Assistance Program (IRAP) is a government agency funded through NRC, offering several programs for innovative business projects.
During this event, get an overview of what IRAP is looking to fund, then hear from a panel of Industry Technical Advisors in the Therapeutics, Medical Device and Digital Health spaces as they answer questions regarding:
- Barriers to entry in each market
- What investors are looking for when investing their time and money in these spaces
- Technologies they have funded in each market
- Identifying the best resources in your area to help you find clinical validation, to consult, to supply etc.
Also joining the panel will be a company who has received IRAP funding to share their perspective on the IRAP funding process and what the funds helped them achieve.
10:00 AM | Registration Opens, Networking
10:20 AM | IRAP Overview
10:40 AM | IRAP Industry Technical Advisors Panel
11:45 AM | Q&A
12:00 PM | Lunch and Networking
1:00 PM | Program Close
Lisa Boreanaz | Industrial Technology Advisor - Medical Devices, IRAP read bio»
Paul McVeigh | Industrial Technology Advisor - Therapeutics, IRAP read bio»
Carol Slama | Industrial Technology Advisor - Digital Health, IRAP read bio»
Jessica Ching | Co-Founder and CEO, Eve Medical (IRAP funded company) read bio»
[moderator] Rebecca Yu | Head of JLABS @ Toronto, Johnson & Johnson Innovation, JLABS read bio»
$40 | General Public
$30 | Student/Academic
$55 | At the door
Please note: fees do not go to the presenting representatives, they cover only catering and event costs
JLABS @ Toronto
661 University Ave, Suite 1300
This event is presented in partnership with OBIO.
Lisa Boreanaz | Industrial Technology Advisor - Medical Devices, IRAP
Lisa Boreanaz is MedTech professional with over twenty years of experience supporting the growth of the Canadian MedTech sector. Lisa is currently on assignment as a Policy Lead (Industry) with Ontario's Chief Health Innovation Strategist supporting the office's priority to optimize pathways to adoption and diffusion for innovative Ontario health technologies. Her previous roles include, seven years as an Industrial Technology Advisor (ITA) with the National Research Council-Industrial Research Assistance Program (NRC-IRAP), where Lisa assisted Canadian companies through all aspects of the innovation process from concept to commercialization. As part of the funding process, Lisa regularly conducted scientific and business due diligence on MedTech ventures across Canada. Prior to joining NRC-IRAP, Lisa worked for, and consulted with, some of the top medical device manufacturers where she held leadership roles in R&D, Manufacturing and Quality, and Regulatory Affairs.
Paul McVeigh | Industrial Technology Advisor - Therapeutics, IRAP
Paul McVeigh is a Life Sciences professional and entrepreneur with more than 25 years of experience in the biotech industry. Prior to his current role with NRC IRAP Paul's experience included small/medium (SME) and multinational biotech enterprises (MNE) as well as his own start-up. His experience spans early stage R&D through to commercial operations, including senior leadership roles in business development, R&D project management, QA/QC, operations, marketing and strategic planning. Paul has had the opportunity to participate in the SME/MNE product development joint ventures from the both the MNE and SME side of table from a business and technical perspective. In 2014 Mr. McVeigh joined IRAP where he has been supporting the SME community through business /technical advisory services, facilitating access to expertise and financial support of innovative high growth potential firms. He is a member of IRAP Biomedical sector team focusing on the development of strategies and tools to integrate SMEs into the global value chain from a pan Canadian perspective.
Connect with Paul:
Carol Slama | Industrial Technology Advisor - Digital Health, IRAP
As one of NRC-IRAP's Industrial Advisors serving the downtown Toronto area, Carol Slama manages a portfolio of client companies, providing advisory services and linkages in the digital health sector, and funded support for their innovative technology development projects. She has also been involved with bringing Ideation and Innovation Management tools to the IRAP client community. In the digital health space, Ms. Slama has facilitated SME access to technical expertise in interoperability, mobile development, and testing capabilities from Mohawk College, and the evaluative expertise in clinical, business, and policy of Women's College Hospital's Institute for Health Systems Solutions and Virtual Care (WIHV). With her knowledge of the challenges and opportunities for digital health innovators, Ms. Slama is a valuable resource for Canadian SMEs looking to access support in the digital health ecosystem.
Connect with Carol:
Jessica Ching | Co-Founder and CEO, Eve Medical ( IRAP funded company)
Jessica Ching is the Co-Founder and CEO of Eve Medical. Following her passion to integrate design and healthcare, she developed HerSwab - a device that enables women to self-collect samples for STI (sexually transmitted infections) testing. She then co-founded Eve Medical with a mission to improve women's health by preventing cervical cancer and pelvic inflammatory disease. Since then, she and her team have brought HerSwab from early concept to commercial launch. The company is now working on launching Eve Kit (evekit.com), Canada's first home screening service for STIs. Jessica is a recipient of the Martin Walmsley Fellowship for Technological Entrepreneurship and was named a 2016 Change Agent by Canadian Business.
Connect with Jessica:
Rebecca Yu | Head of JLABS @ Toronto, Johnson & Johnson Innovation, JLABS
Rebecca Yu is Head of JLABS @ Toronto. Prior to joining Janssen in 2012, Rebecca has enjoyed a 15 year career in the pharmaceutical industry taking on progressive senior roles in the areas of Health Policy, Medical Affairs, and Government Affairs with Solvay Pharma, Procter & Gamble, and Pfizer. She has been involved in innovation initiatives including bringing the J&J Innovation's JLABS incubator model to Toronto and connecting J&J and the University of Toronto together in creating Neuroscience Catalyst. This exciting collaboration funds early-stage investigations in the clinical treatments for mood disorders and Alzheimer's disease; chronic diseases that impact hundreds of millions of people worldwide. Rebecca is currently a member of the Joint Steering Committee for the Neuroscience Catalyst Collaboration along with representatives from the University of Toronto, Centre for Addiction and Mental Health (CAMH), St. Michael's Hospital, MaRS Innovation, Ontario Centre for Excellence (OCE) and Johnson & Johnson. Rebecca is a graduate of University of Toronto, Faculty of Pharmacy. Rebecca is currently a licensed and practicing pharmacist in Ontario. Prior to joining the pharmaceutical industry, she practiced as a Clinical Pharmacist for almost 10 years at The Wellesley Hospital focusing in the areas of the ICU, Burn Unit, Gastroenterology, Rheumatology, and Cardiology.
Connect with Rebecca:
When & Where
JLABS @ Toronto
JLABS, part of Johnson & Johnson Innovation, is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. JLABS offers singular bench tops, modular wet lab units and office space on a short-term basis, allowing companies to pay only for the space they need, with an option to quickly expand when they have the resources to do so. Companies residing at JLABS also have access to core research labs hosting specialized capital equipment and shared administrative areas. JLABS is an open innovation model, and the agreement for space does not grant JLABS or Johnson & Johnson Innovation any stake or rights in the companies, nor will the companies have a guaranteed future affiliation with JLABS. The flagship facility is located in San Diego at Janssen's West Coast Research Center, and JLABS has now two established locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility - one in Boston through a collaboration with Lab Central, one in Houston through a collaboration with TMC, and one in Toronto through a collaboration with MaRS. For more information please visit jlabs.jnjinnovation.com.